Shareholder plans sale of 8,571 common shares

A shareholder has filed a Form 144 notice for the planned sale of 8,571 shares of common stock.

Accepted by SEC EDGAR 01/16/2026 - 05:55 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder has filed a Form 144 notice for the planned sale of 8,571 shares of common stock. The shares are expected to be sold on or about 01/16/2026 on the NYSE through J.P. Morgan Securities LLC, with an indicated aggregate market value of $2,680,888.09. The issuer has 2,696,272,576 shares outstanding.

The securities being sold were acquired on 01/13/2026 from the issuer as equity compensation in the form of awards granted by the issuer. By signing the notice, the selling person represents that they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JPM-related shares are planned to be sold under this Form 144?

The Form 144 covers a planned sale of 8,571 shares of common stock.

What is the aggregate market value of the shares in this JPM Form 144?

The planned sale has an indicated aggregate market value of $2,680,888.09.

How and when were the shares in this JPM Form 144 acquired?

The 8,571 shares were acquired on 01/13/2026 from the issuer as equity compensation resulting from awards granted by the issuer.

On which exchange and through which broker will these JPM-related shares be sold?

The shares are expected to be sold on the NYSE through J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, NY 10017-2014.

How many issuer shares are outstanding in this JPM-related Form 144 filing?

The Form 144 indicates there are 2,696,272,576 shares of the issuer’s common stock outstanding.

What representation does the selling person make in this Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

What is SEC Form 144 generally used for in relation to JPM shares?

Form 144 is a notice filed when an affiliate or other covered holder intends to sell restricted or control securities, such as these 8,571 common shares, in reliance on Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001775584
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JPMORGAN CHASE & CO.
SEC File Number	001-05805
Address of Issuer	270 Park Avenue New York NEW YORK 10017
Phone	2122702978
Name of Person for Whose Account the Securities are To Be Sold	Jennifer Piepszak
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Operating Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue New York NY 10017-2014	8571	2680888.09	2696272576	01/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock. $1 Par Value	01/13/2026	Acquired as a result of awards granted by Issuer	Issuer			8571	01/13/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Holly Youngwood under POA on behalf of Jennifer Piepszak
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)